Monoclonal antibodies against melanoma-associated antigens,...

Details Monoclonal antibodies against melanoma-associated antigens,... Monoclonal antibodies against melanoma-associated antigens,...

C - Chemistry, Metallurgy

12

N

167/139, 195/1.1

C12N 5/12 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) A61P 31/00 (2006.01) C07K 16/30 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) G01N 33/58 (2006.01)

Patent

CA 1341198

The present invention is directed to monoclonal antibodies, and hybridomas which produce them, which are reactive with ganglioside antigens GD2 and GD3 and are essentially non-reactive with other ganglioside antigens. The invention further relates to methods of using these antibodies.

559366

Affiliated with

Also associated with

Rating

Monoclonal antibodies against melanoma-associated antigens,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies against melanoma-associated antigens,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against melanoma-associated antigens,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1281756